4//SEC Filing
Singh Nikhilesh N 4
Accession 0001181431-13-002501
CIK 0001178711other
Filed
Jan 7, 7:00 PM ET
Accepted
Jan 8, 7:05 PM ET
Size
12.8 KB
Accession
0001181431-13-002501
Insider Transaction Report
Form 4
Singh Nikhilesh N
SVP & Chief Scientific Officer
Transactions
- Award
Common Stock Option (right to buy)
2013-01-07+120,000→ 120,000 totalExercise: $5.40Exp: 2023-01-07→ Common Stock (120,000 underlying)
Holdings
- 295(indirect: See footnote)
Common Stock
- 78,206(indirect: See footnote)
Common Stock
- 2,699
Common Stock
Footnotes (4)
- [F1]This total includes 1,145 shares purchased on November 30, 2012 under the 2009 Employee Stock Purchase Plan.
- [F2]Shares held directly by the Reporting Person's spouse.
- [F3]Shares held directly by the Singh Family Trust (the "Family Trust") for which Reporting Person's spouse serves as trustee. The Reporting Person disclaims beneficial ownership of the shares held by the Family Trust except to the extent of his pecuniary interest therein.
- [F4]The option vests in forty-eight equal monthly installments beginning on February 7, 2013.
Issuer
Transcept Pharmaceuticals Inc
CIK 0001178711
Entity typeother
Related Parties
1- filerCIK 0001454351
Filing Metadata
- Form type
- 4
- Filed
- Jan 7, 7:00 PM ET
- Accepted
- Jan 8, 7:05 PM ET
- Size
- 12.8 KB